{"id":2486,"date":"2023-08-14T10:55:03","date_gmt":"2023-08-14T05:55:03","guid":{"rendered":"https:\/\/cemb.edu.pk\/wp\/?page_id=2486"},"modified":"2025-06-02T16:31:07","modified_gmt":"2025-06-02T11:31:07","slug":"fp-dr-nadeem-ahmed","status":"publish","type":"page","link":"https:\/\/www.cemb.edu.pk\/?page_id=2486","title":{"rendered":"Dr Nadeem Ahmed"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

FACULTY<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t



Dr Nadeem Ahmed<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Associate Professor
<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u00a0<\/span><\/h2>

Biopharmaceuticals and Proteomics Lab<\/a><\/span>
e-mail: nadeem.ahmed@cemb.edu.pk<\/span><\/span><\/span><\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr Nadeem Ahmed is Associate Professor at the Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore. He is head of Biopharmaceuticals and Proteomics Laboratory (ISO 9001:2015 Certified). His research interest is Biopharmaceuticals, Biosimilar, Anticancer proteins and fusion peptides, and drug delivery systems. He has developed technology for indigenous production of Taq Polymerase, HotStart Polymerase, Pfu Polymerase, Reverse transcriptase, 2X PCR Mix, qPCR Mix, 2X HotStart Mix. His developed Human recombinants therapeutics are Interferon alpha, Filgrastim, PEGfilgrastim, Proleukin, Thrombex. He has published more than 39 international publication. He supervised 52 M.Phils. Five Ph.D. and many internship students at CEMB. He developed first ISO 9001-2015 certified protein production facility at CEMB.<\/p>

Selected Publications:<\/b><\/p>

  1. Ashraf, F., Khan, M. A., Ahmed, N., Umar, M., Khan, M. I., Akram, M., Bhatti, R., & Malik, K. (2023). Development of transgenic algae strain expressing CTB-M2e fusion gene an approach towards the development of a universal edible vaccine in Algae. Journal of Biotechnology. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jbiotec.2023.07.004<\/li>
  2. Fujimura, N. A., Fatima, S. E., Ahmed, N., Akram, M., Tahir, S., Khan, M. A., Amirzada, I., Nadeem, T., Bashir, H., & Malik, K. (2023). Evaluation of exosomes encapsulated recombinant Interleukin-29 for its in vitro anticancer studies. Journal of Biotechnology, 373, 24-33. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jbiotec.2023.06.008<\/li>
  3. Majeed, S., Qaiser, M., Shahwar, D., Mahmood, K., Ahmed, N., Hanif, M., Abbas, G., Shoaib, M. H., Ameer, N., & Khalid, M. (2023). Chitosan-coated halloysite nanotube magnetic microspheres for carcinogenic colorectal hemorrhage and liver laceration in albino rats. RSC Advances, 13(31), 21349-21364. https:\/\/doi.org\/10.1039\/D3RA01581E<\/li>
  4. Aslam, S., Rehman, H. M., Sarwar, M. Z., Ahmad, A., Ahmed, N., Amirzada, M. I., \u2026 & Bashir, H. (2023). Computational Modeling, High-Level Soluble Expression and In Vitro Cytotoxicity Assessment of Recombinant Pseudomonas aeruginosa Azurin: A Promising Anti-Cancer Therapeutic Candidate. Pharmaceutics, 15(7), 1825. https:\/\/doi.org\/10.3390\/pharmaceutics15071825<\/li>
  5. Munir, A., Ahmed, N., Akram, M., Fujimura, N. A., Tahir, S., & Malik, K. (2023). Enhanced soluble expression of active recombinant human interleukin-29 using champion pET SUMO system. Biotechnology Letters. https:\/\/doi.org\/10.1007\/s10529-023-03402-x<\/li>
  6. Ullah, A., Rehman, I. U., Ommer, K., Ahmed, N., Odenthal, M., \u2026 & Ahmad, B. (2023). Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3. Genes, 14(5), 1056. https:\/\/doi.org\/10.3390\/genes14051056<\/li>
  7. Rahman, Z. U., Ahmed, N., Fazal, N., Khan, M. I., Khan, M. A., Tahir, S., Akram, M., Ullah, S., & Zafar, A. U. (2023). Enhancing the Expression and Purification of IL-29: A study of autoinduction and one-step Purification Methods. Advancements in Life Sciences, 10(1), 122-128. http:\/\/www.als-journal.com\/proonlinefirst-1730\/<\/li>
  8. Nadeem, T., Ahmed, N., Khan, M. I., & Bashir, H. (2023). Establishment of Potent Anti-Inflammatory IL-1ra Superkine Antagonist Using E. Coli BL21 (DE3) Strain. Journal of Tianjin University Science and Technology, 56(4:2023). https:\/\/tianjindaxuexuebao.com\/dashboard\/uploads\/7.RHE2M.pdf<\/li>
  9. Khan, H., Khan, M. A., Ahmed, N., Tawakkal, F., Amjad, F., & Pervaiz, R. (2023). A 90-day subchronic oral toxicity assessment of Chlamydomonas reinhardtii biomass, genetically modified to express cry11Ba protein, by using Han Wistar rats. Journal of Applied Phycology, 1-13. https:\/\/doi.org\/10.1007\/s10811-023-02950-z<\/li>
  10. Rafiq, A., Zareen, G., Akbar, S., Asif, M., Ahmed, N., Bibi, N., Habiba, U., Khan, A.U., Shaikh, R.S. and Iqbal, F. (2023). Association of genotypes at rs438228855 in Bovine SLC35A3 Receptor gene of Pakistani cattle with the susceptibility to develop complex vertebral malformation. Reproduction in Domestic Animals. https:\/\/doi.org\/10.1111\/rda.14346<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tResume<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tResearch Gate<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n\t\t\t\t\t
    \n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

    FACULTY Dr Nadeem Ahmed Associate Professor \u00a0 Biopharmaceuticals and Proteomics Labe-mail: nadeem.ahmed@cemb.edu.pk Dr Nadeem Ahmed is Associate Professor at the Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore. He is head of Biopharmaceuticals and Proteomics Laboratory (ISO 9001:2015 Certified). His research interest is Biopharmaceuticals, Biosimilar, Anticancer proteins and fusion peptides, and […]<\/p>\n","protected":false},"author":96739698,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-2486","page","type-page","status-publish","hentry","entry"],"_links":{"self":[{"href":"https:\/\/www.cemb.edu.pk\/index.php?rest_route=\/wp\/v2\/pages\/2486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cemb.edu.pk\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cemb.edu.pk\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cemb.edu.pk\/index.php?rest_route=\/wp\/v2\/users\/96739698"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cemb.edu.pk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2486"}],"version-history":[{"count":36,"href":"https:\/\/www.cemb.edu.pk\/index.php?rest_route=\/wp\/v2\/pages\/2486\/revisions"}],"predecessor-version":[{"id":17674,"href":"https:\/\/www.cemb.edu.pk\/index.php?rest_route=\/wp\/v2\/pages\/2486\/revisions\/17674"}],"wp:attachment":[{"href":"https:\/\/www.cemb.edu.pk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}